HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged vital suppression

Nature Medicine

Volumn 5, Issue 5, 1999, Pages 518-525

  Pitcher, Christine J ^a   Quittner, Claudia ^b   Peterson, Dolores M ^b   Connors, Mark ^c   Koup, Richard A ^b   Maino, Vernon C ^d   Picker, Louis J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d BD Technologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CYTOKINE; GAG PROTEIN;

ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL MEMORY; LYMPHOCYTE COUNT; MEMORY CELL; PRIORITY JOURNAL; VIRUS INHIBITION;

EID: 0032941595     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/8400     Document Type: Article

References (34)

1. Johnson, R.P., Siliciano, R.F. & McElrath, M.J. Cellular immune responses to HIV-1. AIDS 12, S113-S120 (1998).
2. + cell suppressor factors and cytotoxic T lymphocytes during HIV infection. AIDS Res. Hum. Retroviruses 14, S153-S160 (1998).
3. Steinman, R.M. & Germain, R.N. Antigen presentation and related immunological aspects of HIV-1 vaccines. AIDS 12, S97-S112 (1998).
4. Ogg, G.S. et al. Quantitation of HIV-1 - Specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279, 2103-2106 (1998).
5. Matano, T. et al. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J. Virol. 72, 164-169, 1998.
6. Levy, J.A. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57, 183-289 (1993).
7. Valentine, F.T., Palino, A., Saito, A. & Holzman, R.S. Lymphocyte-proliferative responses to HIV antigens as a potential measure of immunological reconstituion in HIV disease. AIDS Res. Hum. Retroviruses 14, S161-S166 (1998).
8. Rosenberg, E.S. & Walker, B.D. HIV type 1-specific helper T cells: A critical host defense. AIDS Res. Hum. Retroviruses 14, S143-S147 (1998).
9. Moss, R.B. et al. A primer on HIV type 1-specific immune function and remune ™. AIDS Res. Hum. Retroviruses 14, S167-S175 (1998).
10. Schwartz, D. et al. Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor. AIDS Res. Hum. Retroviruses 10, 1703-1711 (1994).
11. + T cell responses associated with control of viremia. Science 278, 1447-1450 (1997).
12. Groux, H. et al. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175:331-340 (1992).
13. Cottrez, F. et al. Priming of human CD4+ antigen-specific T cells to undergo apoptosis by HIV-infected monocytes. J. Clin. Invest. 99, 257-266 (1997).
14. Clerici, M. et al., Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and effected by lymphotoxin. AIDS 10, 603-611 (1996).
15. + T lymphocytes induced by peptide immunization: an ex vivo analysis. Int. Immunol. 10, 1273-1270 (1998).
16. Matloubian, M., Concepcion, R.J. & Ahmed, R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J. Virol. 68, 8056-8063 (1994).
17. Battegay, M. et al. Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. J. Viro. 68, 4700-4704 (1994).
18. von Herrath, M.G., Yokoyama, M., Dockter, J., Oldstone, M.B.A. & Whitton, J.L. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J. Virol. 70, 1072-1079 (1996).
19. Cardin, R.D., Brooks, J.W. & Sarawar, S.R., Progressive loss of CD8+ T cell-mediated control of a γ-Herpesvirus in the absence of CD4+ T cells. J. Exp. Med. 184, 863-871 (1996).
20. Walter, E.A. et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T cell clones from the donor. N. Engl. J. Med. 333, 1038-1044 (1995).
21. Waldrop, S.L., Pitcher, C.J., Peterson, D.M., Maino, V.C. & Picker, L.J. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry. J. Clin. Invest. 99, 1739-1750 (1997).
22. Waldrop, S.L., Davis, K.A., Maino V.C. & Picker L.J. Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis, J. Immunol. 161, 5284-5295 (1998).
23. Komanduri, K. V. et al. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nature Med. 4, 953-956 (1998).
24. Haase, A.T. Population biology of HIV-1 infection: Vital and CD4+ T cell demographics and dynamics in lymphatic tissues. Annu. Rev. Immunol. 17, 625-656 (1999).
25. Cavert, W. et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 276, 960-964 (1997).
26. Callahan, K.M., Fort, M.M., Obah, E.A., Reinherz, E.L. & Siliciano, R.F., Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor. J. Immunol. 144, 3341-3346 (1990).
27. Harcourt, G.C., Garrand, S., Davenport, M.P., Edwards, A. & Phillips, R.E. HIV-1 variation diminishes CD4 T lymphocyte recognition. J. Exp. Med. 188, 1785-1794 (1998).
28. Butcher, E.C. & Picker, L.J. Lymphocyte homing and homeostasis. Science 272, 60-66 (1996).
29. Andersson, J. et al. Early reduction of immune activation in lymphoid tissue following highly active HIV therapy. AIDS 12, F123-F129 (1998).
30. Hellerstein, M. et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nature Med. 5, 83-89 (1999).
31. Gorochev, G. et al. Perturbation of CD4+ and CD8+ T cell repertoires during progression to AIDS and reulation of the CD4+ repertoire during antiviral therapy. Nature Med. 4, 215-221 (1998).
32. Mackall, C.L. & Gress, R.E. Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy. Immunol. Rev. 157, 61-72 (1997).
33. Wong, J.K. et al. Recovery of replication-competent HIV despite suppression plasma viremia. Science 278, 1291-1295 (1997).
34. Collins, R.H. Jr. et al. Immune reconstitution with donor-derived memory/effector T cells after orthotopic liver transplantation, Exp. Hematol. 25, 147-159 (1997).